Una Ryan, OBE, Ph.D. joined Quince Therapeutics’ Board of Directors in January 2019 and serves as its Lead Independent Director. To this role Dr. Ryan brings a deep background in the biopharma space, including extensive experience serving on the boards of public, private and non-profit companies. She has served as a Managing Director at Golden Seeds LLC since 2012, a Partner at Astia Angel since 2012, and a Limited Partner at Breakout Ventures since 2016. Previously, Dr. Ryan was Chairman of The Bay Area BioEconomy Initiative. Additionally, she served as the President and Chief Executive Officer at Waltham Technologies, Inc. and as Chief Executive Officer, President, and Chief Operating Officer of AVANT Immunotherapeutics Inc. (which then became known as Celldex, Inc) for ten years. Dr. Ryan also served as the President and Chief Executive Officer of Diagnostics for All, or DFA, and as Director of Health Sciences at Monsanto Corporation. She serves on the board of directors of the following non-profit entities: Cambridge in America, the University of Bristol Foundation and the San Francisco Art Institute. Dr. Ryan previously served as a director on the board of directors for AVANT Immunotherapeutics, Inc, Nativis, Inc., AMRIGlobal, Inc, BayBio, MassBio, BIO, or Biotechnology Innovation Organization, New England Healthcare Institute, Board of Associates of the Whitehead Institute and Strategy & Policy Council of the MIT Center for Biomedical Innovation. As a scientist, Dr. Ryan is credited with the localization of angiotensin converting enzyme as a target that led to the development of an important class of blood pressure medicines. In 2002, Queen Elizabeth II awarded Dr. Ryan the Order of the British Empire (OBE) for services to biotechnology. She subsequently received the Albert Einstein Award for outstanding achievement in the life sciences in 2007, as well as the Cartier Women’s Initiative Award in 2009. Dr. Ryan holds a B.S. in Zoology, Microbiology, Chemistry from Bristol University and a Ph.D. in Cellular and Molecular Biology from Cambridge University.